In vitro, molecular docking and in silico adme/tox studies of emodin and chrysophanol against human colorectal and cervical carcinoma

HIGHLIGHTS

• who: Wasim Ahmad et al. from the Department of Pharmacy, Mohammed Al-Mana College for Medical Sciences, Dammam, Saudi Arabia Imam Abdulrahman Bin Faisal University, Dammam, Saudi Arabia have published the research: In Vitro, Molecular Docking and In Silico ADME/Tox Studies of Emodin and Chrysophanol against Human Colorectal and Cervical Carcinoma, in the Journal: Pharmaceuticals 2022, 1348 of 18/01/2022
• what: In this study anthraquinone aglycons (Chr) (EM) and FDA-approved anticancer drug fluorouracil were analyzed by molecular docking studies receptor molecules caspase-3 apoptosis regulator Bcl-2 TRAF2 and NCK-interacting protein . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or Email

  Password

  Remember me

  Lost your password?

  If you don't have an account, you can create one here.